NASOPEN description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

NASOPEN

GM Pharmaceuticals, Inc.

NASOPEN


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients
(in each 5 mL teaspoonful)

Chlorcyclizine Hydrochloride 9.375 mg
Pseudoephedrine Hydrochloride 30 mg

Purpose

Antihistamine
Nasal Decongestant

NASOPEN Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • nasal congestion
  • reduces swelling of the nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • difficulty in urination due to the enlargement of the prostate gland
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes

Ask a doctor before use if you are taking sedatives or tranquilizers.

When using this product

  • excitability may occur, especially in children
  • may cause drowsiness
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase the drowsiness effect
  • use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

  • nervousness, dizziness, or sleeplessness occurs
  • symptoms do not improve within 7 days or accompanied by fever.
  • new symptoms occur

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Do not exceed recommended dosage.
Adults and children
12 years of age
and older:

2 teaspoonfuls (10 mL)
every 6 hours, not to
exceed 8 teaspoonfuls in a
24 hour period.
Children 6 to under
12 years of age:


1 teaspoonful (5 mL)
every 6 hours, not to
exceed 4 teaspoonfuls
in a 24 hour period.
Children under 6
years of age:
consult a doctor


Other Information

Store at 59° to 86°F (15° to 30­°C).

Inactive Ingredients

Citric Acid, Cotton Candy Flavor, Glycerin, Propylene Glycol, Purified Water, Sodium Citrate, Sorbitol, and Sucralose.

Questions? Comments?

Call 1-888-535-0305

Product Packaging

The packaging below represents the labeling currently used:

Principal display panel and side panel for 473 mL label:

NDC 58809-578-01

NASOPEN

Each 5 mL (one Teaspoonful) contains:

Chlorcyclizine HCl...................9.375 mg
Pseudoephedrine HCl...................30 mg

Antihistamine / Nasal Decongestant

Cotton Candy Flavor

Alcohol Free / Gluten Free
Sugar Free / Dye Free

16 fl. oz. (473 mL)

GM Pharmaceuticals, Inc.


Tamper evident by foil seal under cap.  Do not use if foil seal is broken or missing.

Dispense in a tight, light-resistant container with a child-resistant cap.

This bottle is not to be dispensed to consumer.

Distributed by: GM Pharmaceuticals, Inc.
                          Arlington, Tx  76012

Patent Pending

Iss. 04/11

NASOPEN

NASOPEN



NASOPEN

Chlorcyclizine Hydrochloride, Pseudoephedrine Hydrochloride LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:58809-578
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlorcyclizine Hydrochloride Chlorcyclizine 9.375 mg
Pseudoephedrine Hydrochloride Pseudoephedrine 30 mg

Inactive Ingredients

Ingredient Name Strength
CITRIC ACID MONOHYDRATE
GLYCERIN
propylene glycol
water
SODIUM CITRATE
sorbitol
Sucralose

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:58809-578-01 473 in 1 BOTTLE
2 15 in 1 BOTTLE
3 NDC:58809-578-02 12 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part341 2011-06-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.